Generated by All in One SEO v4.9.9, this is an llms.txt file, used by LLMs to index the site.

# CARAMBA

CARAMBA

## Sitemaps

- [XML Sitemap](https://www.caramba-cart.eu/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Video interviews with CARAMBA researchers](https://www.caramba-cart.eu/video-interviews-with-caramba-researchers/)
- [The pioneering CARAMBA project is coming to an end](https://www.caramba-cart.eu/caramba-project-end/)
- [CARAMBA Meeting Report](https://www.caramba-cart.eu/caramba-meeting-report/)
- [6th CARAMBA General Assembly meeting in Frankfurt](https://www.caramba-cart.eu/6th-caramba-general-assembly-meeting-in-frankfurt/)
- [T-CURX GmbH announces the appointment of Thomas Loeser as CFO](https://www.caramba-cart.eu/tcurx-announces-thomas-loeser-as-cfo/)
- [Congratulations to Monica Casucci for receiving her ERC grant](https://www.caramba-cart.eu/monica-caucci-receiving-erc-grant/)
- [Revolutionary Immune Cells: Michael Hudecek receives Schelling-Price for Innovative Cancer Research](https://www.caramba-cart.eu/michael-hudecek-receives-schelling-price/)
- [Status and perspective of CART cell therapy trials in Germany](https://www.caramba-cart.eu/status-and-perspective-of-cart-cell-therapy-trials-in-germany/)
- [Great success of the 5th Digital Myeloma Forum](https://www.caramba-cart.eu/great-success-of-the-5th-digital-myeloma-forum/)
- [VJHemOnc interviewing Michael Hudecek](https://www.caramba-cart.eu/vjhemonc_interview/)
- [VJHemOnc interviewing Hermann Einsele](https://www.caramba-cart.eu/vjhemonc-interviewing-hermann-einsele/)
- [CARAMBA publication in Gene Therapy](https://www.caramba-cart.eu/caramba-publication-in-gene-therapy/)
- [CARAMBA at the 4th European CART Cell Meeting](https://www.caramba-cart.eu/caramba-at-the-4th-european-cart-cell-meeting/)
- [White Paper on CAR-T cell therapy development](https://www.caramba-cart.eu/white-paper-on-car-t-cell-therapy-development/)
- [Myeloma Pipeline - MPE publishes clinical trial information sheet](https://www.caramba-cart.eu/myeloma-pipeline-mpe-publishes-clinical-trial-information-document/)
- [CARAMBA at the 3rd European CAR-T workshop](https://www.caramba-cart.eu/caramba-at-the-3rd-european-car-t-workshop/)
- [1st European CAR-T workshop](https://www.caramba-cart.eu/caramba-at-the-1st-european-car-t-workshop/)
- [CARAMBA Kick-off Meeting](https://www.caramba-cart.eu/caramba-kick-off-meeting/)
- [MPE launches Horizon2020 CARAMBA video](https://www.caramba-cart.eu/mpe-launches-horizon2020-caramba-video/)
- [CARAMBA at EHA 2018](https://www.caramba-cart.eu/eha2018/)
- [CARAMBA Flyer available](https://www.caramba-cart.eu/caramba-flyer-available/)
- [2nd CARAMBA General Assembly in Wuerzburg](https://www.caramba-cart.eu/2nd-caramba-general-assembly-in-wuerzburg/)
- [Myeloma Patients Europe General Assembly](https://www.caramba-cart.eu/myeloma-patients-europe-general-assembly/)
- [Myeloma Patients Europe webinar on CAR-T cell treatment](https://www.caramba-cart.eu/myeloma-patients-europe-webinar-on-car-t-cell-treatment/)
- [Publication: Genomic Analyses of SLAMF7 CAR-T Cells](https://www.caramba-cart.eu/publication-genomic-analyses-of-slamf7-car-t-cells/)
- [Joint regulatory workshop of EURE-CART and CARAMBA](https://www.caramba-cart.eu/joint-regulatory-workshop-of-eure-cart-and-caramba/)
- [REGULATORY WORKSHOP ON THE DEVELOPMENT OF CAR-T CELLS](https://www.caramba-cart.eu/regulatory-workshop-on-the-development-of-car-t-cells/)

## Pages

- [Home](https://www.caramba-cart.eu/) - CARAMBA is an H2020 project that will provide a phase I/II CAR-T clinical trial to Multiple Myeloma patients.
- [Team](https://www.caramba-cart.eu/team/) - The CARAMBA Consortium consists of ten partners from six different European countries.
- [Project](https://www.caramba-cart.eu/the-project/) - CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease
- [Meeting Registration](https://www.caramba-cart.eu/meeting-registration/)
- [Patients](https://www.caramba-cart.eu/patients/) - The safety and efficacy of SLAMF7 CAR-T cells will be assessed in multiple myeloma patients through a Phase I/II clinical trial involving around 30 patients.
- [Contact](https://www.caramba-cart.eu/contact/)
- [Imprint & Disclaimer](https://www.caramba-cart.eu/imprint-disclaimer/)
- [EURE-CART/CARAMBA joint open regulatory workshop](https://www.caramba-cart.eu/eure-cart-caramba-joint-open-regulatory-workshop/) - CAR-T regulatory workshop in Sitges
- [News](https://www.caramba-cart.eu/news/)
- [EURE-CART/CARAMBA joint regulatory workshop](https://www.caramba-cart.eu/eure-cart-caramba-joint-regulatory-workshop/) - CAR-T regulatory workshop in Sitges
- [Privacy Policy](https://www.caramba-cart.eu/privacy-policy/)
- [Copyright](https://www.caramba-cart.eu/copyright/)
- [Cookie Policy](https://www.caramba-cart.eu/cookie-policy/)
- [Investors](https://www.caramba-cart.eu/investors/)
- [Press Release](https://www.caramba-cart.eu/press_release/)

## Categories

- [Uncategorized](https://www.caramba-cart.eu/category/uncategorized/)